Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA370845
Max Phase: Preclinical
Molecular Formula: C3H8NO7PS
Molecular Weight: 233.14
Molecule Type: Small molecule
Associated Items:
ID: ALA370845
Max Phase: Preclinical
Molecular Formula: C3H8NO7PS
Molecular Weight: 233.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS(=O)(=O)NC(=O)COP(=O)(O)O
Standard InChI: InChI=1S/C3H8NO7PS/c1-13(9,10)4-3(5)2-11-12(6,7)8/h2H2,1H3,(H,4,5)(H2,6,7,8)
Standard InChI Key: KRLKYDJDPJABAK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 233.14 | Molecular Weight (Monoisotopic): 232.9759 | AlogP: -1.83 | #Rotatable Bonds: 4 |
Polar Surface Area: 130.00 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.27 | CX Basic pKa: | CX LogP: -2.49 | CX LogD: -6.91 |
Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.49 | Np Likeness Score: -0.09 |
1. Gavalda S, Braga R, Dax C, Vigroux A, Blonski C.. (2005) N-Sulfonyl hydroxamate derivatives as inhibitors of class II fructose-1,6-diphosphate aldolase., 15 (24): [PMID:16236509] [10.1016/j.bmcl.2005.09.006] |
Source(1):